SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 12, 2025
 · 
4 min read
Press Releases
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
December 12, 2025
 · 
6 min read
Press Releases
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
December 12, 2025
 · 
6 min read
Press Releases
Wobble Genomics To Present New Data At SABCS Confirming Platform’s Ability To Determine Detailed Profiling of HER2 Status in Tissue and Blood
December 12, 2025
 · 
2 min read
Press Releases
Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium
December 12, 2025
 · 
4 min read
Press Releases
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
December 12, 2025
 · 
5 min read
Press Releases
AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
December 12, 2025
 · 
7 min read
Press Releases
Cadwell and Medical Informatics Corp. Announce Partnership to Bring Neurodiagnostic Data into Clinical Intelligence Ecosystem
December 12, 2025
 · 
3 min read
Press Releases
Changes to the Executive Management
December 12, 2025
 · 
2 min read
Press Releases
Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium
December 12, 2025
 · 
5 min read
Press Releases
Science Corporation Names Darius Shahida as Chief Strategy Officer
December 12, 2025
 · 
3 min read
Press Releases
Subsense Expands Financing to $27 Million to Accelerate R&D for Non-Surgical Brain-Computer Interfaces
December 12, 2025
 · 
2 min read
Press Releases
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
December 12, 2025
 · 
6 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
 · 
3 min read
Press Releases
Prilenia and Ferrer Announce FDA Clearance to Start the “PREVAiLS” Pivotal Phase 3 Study with Pridopidine in ALS
December 12, 2025
 · 
9 min read
Press Releases
Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*
December 12, 2025
 · 
5 min read
Press Releases
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
December 12, 2025
 · 
5 min read
Press Releases
The PHERGuide study demonstrates the utility of circulating tumor DNA for the early detection and real-time monitoring of localized HER2+ breast cancer
December 12, 2025
 · 
6 min read
Press Releases
Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package
December 12, 2025
 · 
7 min read
Press Releases
FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program
December 12, 2025
 · 
2 min read
Press Releases
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
December 12, 2025
 · 
3 min read
Press Releases
Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
December 12, 2025
 · 
4 min read
Press Releases
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
December 12, 2025
 · 
7 min read
Press Releases
Neurenati Therapeutics Welcomes Dr Daniel Guay to Its Board of Directors and Dr Carlo Di Lorenzo to Its Scientific and Clinical Advisory Board
December 12, 2025
 · 
2 min read
Press Releases
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
December 12, 2025
 · 
8 min read
Press Releases
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
December 12, 2025
 · 
6 min read
Press Releases
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
December 12, 2025
 · 
1 min read
Press Releases
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
December 12, 2025
 · 
3 min read
Press Releases
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
December 12, 2025
 · 
3 min read
Press Releases
Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
December 12, 2025
 · 
7 min read
Press Releases
Orphalan announces acquisition of Orphelia Pharma
December 12, 2025
 · 
2 min read
Press Releases
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
December 12, 2025
 · 
6 min read
Press Releases
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
December 12, 2025
 · 
4 min read
Press Releases
Gaelic Labs’ acquisition of Athlone boosts Gaelic’s leadership in the Beta Lactam industry
Gaelic Laboratories, a world-class manufacturer of Beta-Lactam (penicillin) products, today announces its acquisition of Athlone Laboratories, a leading developer and manufacturer of oral dose Beta-Lactams, in a step that strengthens Gaelic’s market position, enhances manufacturing capabilities, and leverages supply chain efficiencies.
December 12, 2025
 · 
1 min read
Load More